Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.02 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | 1 Parkinson's trial, 1 stopped | 0.20 |
| literature PubMed | 38 Parkinson's papers of 4,509 | 0.52 |
| pathways Reactome | 4 pathways; mostly other | 0.30 |
No case: the score is under the bar. Receipt 7608
Sealed predictions
- ARG1 in dopamine neurons, braak+0.55 (p 0.127) → +0.69 (p 0.040)receipt 7616
Swarm cases
receipt 7616: ARG1 in dopamine neurons, braak
- power
- full sample +0.61 (p 0.0077, n 18), 95% CI +0.19 to +0.84. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: +0.62 (p 0.0062, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.66 (p 0.0031, n 18). not the mix.
- skeptic
- leave-one-out range +0.56 to +0.71, sign flips 0; without severely affected donors +0.61 (p 0.0077, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ARG1 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts